Craig H. Lipset is Head of Clinical Innovation within Worldwide Research & Development at Pfizer. Craig’s team is responsible for impacting clinical research through digital tools, innovative research approaches and unprecedented collaborations. He serves on the Board of Directors for the Foundation for Sarcoidosis Research, the Board of Directors for the MedStar Health Research Institute, the Operations Committee for TransCelerate BioPharma, and as a Mentor at health tech accelerator Blueprint Health. Craig also serves on the Editorial Board for Therapeutic Innovation & Regulatory Science.
Craig previously served as Venture Partner in Pfizer Venture Investments as well as Senior Director in Molecular Medicine within Pfizer R&D. Prior to Pfizer he served as Associate Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International).
Craig’s areas of expertise include patient engagement, applications of digital platforms for clinical research, innovation and change management. His team currently manages Pfizer’s initiatives, investments, and collaborations to re-invent clinical research. In recent years, Craig has been listed among the 2010 PharmaVOICE most inspiring people in the life sciences, featured in Pharmaceutical Executive’s 2011 Emerging Leaders, and his work acknowledged with the 2012 BioIT Best Practices award for Clinical & Health IT.